Correction: Clinical Reviews in Allergy & Immunology (2026) 69:59
10.1007/s12016-026-09187-x
The original online version of this article has been revised. Part of the caption for Figure 2:
“In atopic dermatitis, epidermal barrier dysfunction facilitates chronic exposure to allergens and microbial stimuli, including Staphylococcus aureus, leading to the release of epithelial alarmins by keratinocytes, such as TSLP, IL-25, and IL-33. These signals activate cutaneous antigen-presenting cells, including Langerhans cells and dermal dendritic cells, and initiate antigen-dependent T-cell priming in skin-draining lymph nodes through TCR-MHC recognition and early CD28-CD80/CD86 co-stimulation. Inducible co-stimulatory pathways of the TNFR superfamily, particularly the OX40-OX40L axis, become engaged within the skin following this initial activation phase. OX40 signaling promotes effector T cell expansion, survival, and functional persistence, reinforcing type 2 inflammation during acute disease and supporting a mixed Th2/Th17/Th22 immune profile during the transition to chronic inflammation. Sustained OX40-OX40L engagement contributes to the maintenance of skin-resident memory T cells, epidermal hyperplasia, and long-term inflammatory memory in atopic dermatitis, thereby facilitating disease chronicity and relapse. Created with BioRender.com”
was inadvertently included as a regular paragraph under the “Atopic Dermatitis” section.
The original article has been corrected.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.